indicates the potential for inactivation of β-d-glucosidase along with the high level of α-l-rhamnosidase activity necessary for the production of flavonoid glycosides. The α-l-rhamnosidase from Brevundimonas sp. Ci19 showed interesting properties for potential use not only in the citrus juice industry but also in winemaking.
Ilex paraguariensis St. Hil (yerba mate) is an important crop in the north of Argentina, mainly in Misiones province. The application of Trichoderma as a biocontroller and biofertilizer can replace or reduce the use of agrochemicals, decreasing the negative ecological impact. In this research, we evaluated in vitro and in vivo antagonistic and plant growth promoting (PGP) properties of Trichoderma species isolated from different regions of Misiones province. Dual culture assays of Trichoderma against phytopathogenic fungi associated with yerba mate showed that T. stilbohypoxyli LBM 120 was the most effective antagonist, inhibiting in more than 75% all phytopathogen growth. Trichoderma atroviride LBM 112 and T. stilbohypoxyli LBM 120 were positive on endoglucanase, protease, chitinase, siderophore production, and phosphate solubilisation showed the best biological control agents and PGP properties. The PGP properties of Trichoderma spp. evaluated in vivo on yerba mate seedlings showed that T. atroviride LBM 112, T. stilbohypoxyli LBM 120, and T. koningiopsis LBM 219 enhanced plant dry weight over 47% in total and 24% in the aerial part. Moreover, T. koningiopsis LBM 219 increased root dry weight 25% in contrast with in vitro controls. In conclusion, native Trichoderma strains could be a sustainable solution to improve yerba mate yield.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.